JP2005519119A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519119A5
JP2005519119A5 JP2003573005A JP2003573005A JP2005519119A5 JP 2005519119 A5 JP2005519119 A5 JP 2005519119A5 JP 2003573005 A JP2003573005 A JP 2003573005A JP 2003573005 A JP2003573005 A JP 2003573005A JP 2005519119 A5 JP2005519119 A5 JP 2005519119A5
Authority
JP
Japan
Prior art keywords
formula
defined above
compound
salt
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003573005A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519119A (ja
Filing date
Publication date
Priority claimed from GBGB0205327.0A external-priority patent/GB0205327D0/en
Application filed filed Critical
Publication of JP2005519119A publication Critical patent/JP2005519119A/ja
Publication of JP2005519119A5 publication Critical patent/JP2005519119A5/ja
Pending legal-status Critical Current

Links

JP2003573005A 2002-03-06 2003-03-04 界面活性剤として使用するための化合物 Pending JP2005519119A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0205327.0A GB0205327D0 (en) 2002-03-06 2002-03-06 compounds
PCT/GB2003/000876 WO2003074537A1 (en) 2002-03-06 2003-03-04 Compounds for use as surfactants

Publications (2)

Publication Number Publication Date
JP2005519119A JP2005519119A (ja) 2005-06-30
JP2005519119A5 true JP2005519119A5 (https=) 2006-04-13

Family

ID=9932460

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003573005A Pending JP2005519119A (ja) 2002-03-06 2003-03-04 界面活性剤として使用するための化合物

Country Status (9)

Country Link
US (1) US7354966B2 (https=)
EP (1) EP1480990B1 (https=)
JP (1) JP2005519119A (https=)
AT (1) ATE309253T1 (https=)
AU (1) AU2003212509A1 (https=)
DE (1) DE60302222T2 (https=)
ES (1) ES2250874T3 (https=)
GB (1) GB0205327D0 (https=)
WO (1) WO2003074537A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53514B1 (sr) * 2009-10-02 2015-02-27 Chiesi Farmaceutici S.P.A. Farmaceutske aerosolne formulacije od formoterola i beklometazon dipropionata
GB201205632D0 (en) * 2012-03-30 2012-05-16 Vectura Ltd Method and apparatus

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
NZ222907A (en) * 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
JPH02273536A (ja) * 1989-04-13 1990-11-08 Yakult Honsha Co Ltd 界面活性剤およびその製造法
EP0478686B1 (en) * 1989-06-22 1993-08-11 Applications Et Transferts De Technologies Avancees Atta Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
AU654813B2 (en) 1990-03-23 1994-11-24 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
DE69101639T2 (de) 1990-06-27 1994-10-06 Minnesota Mining & Mfg Anwendung von löslichen fluorhaltigen tensiden zur herstellung von aerosol-präparaten mit dosierter abgabe.
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
CA2085884C (en) * 1990-06-29 2001-12-04 Asit Somani Pressurized hydrofluorocarbon aerosol compositions
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
AP791A (en) 1995-04-14 1999-12-17 Glaxo Wellcome Inc Metered dose inhaler for albuterol.
EP0880530B1 (de) * 1996-02-16 2003-07-02 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Phosphatidyloligoglycerine
US6451287B1 (en) * 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
GB0118364D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Compounds

Similar Documents

Publication Publication Date Title
KR970059181A (ko) 포스포네이트 뉴클레오티드 화합물
JP2006514114A5 (https=)
EP1178072A3 (en) Aromatic liquid-crystalline polyester solution composition
JP2004509159A5 (https=)
CA2506082A1 (en) Novel medicaments for the treatment of chronic obstructive pulmonary disease
JP2003530368A5 (https=)
JP2005529102A5 (https=)
JPH1180578A5 (https=)
JP2005519119A5 (https=)
JP2007500676A5 (https=)
JP2005520864A5 (https=)
JP2005526149A5 (https=)
JP3598168B2 (ja) 抗ウイルス剤
US20060246017A1 (en) Polymerizable phosphoric acid ester derivative and a dental composition employing it
JP2006517932A5 (https=)
JP2018510192A5 (https=)
JP2003509494A5 (https=)
US2146356A (en) Dialkylaminophosphorous fluorides and a process for preparing the same
CN110225905B (zh) 用于保护皮肤免受重金属和甲醛影响的组合物
JPS6160815B2 (https=)
JP2005517701A5 (https=)
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
JP2004317641A5 (https=)
WO2004087681A1 (en) A novel amorphous form of valsartan
JPS584010B2 (ja) 2,2,2− トリフルオロ −1− クロロエチル − エ−テルノ セイゾウホウホウ